2-240045556-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173351.2(OR6B3):c.517G>A(p.Val173Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00003 in 1,564,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173351.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151628Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.0000371 AC: 9AN: 242720Hom.: 0 AF XY: 0.0000380 AC XY: 5AN XY: 131698
GnomAD4 exome AF: 0.0000297 AC: 42AN: 1412544Hom.: 0 Cov.: 24 AF XY: 0.0000298 AC XY: 21AN XY: 705272
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151746Hom.: 0 Cov.: 28 AF XY: 0.0000404 AC XY: 3AN XY: 74170
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2024 | The c.517G>A (p.V173I) alteration is located in exon 1 (coding exon 1) of the OR6B3 gene. This alteration results from a G to A substitution at nucleotide position 517, causing the valine (V) at amino acid position 173 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at